Rize ICAV Medical Cannabis & Life Sciences UCITS ETF GBP (FLWG)
19.60p (3.31%) Previous:
|Index:||The Foxberry Medical Cannabis & Life Sciences Index provides exposure to companies involved in the global medical cannabis and cannabis-related life sciences sectors, with a focus on companies in the biotechnology/pharma and hemp and cannabidiol (CBD) sectors. The index excludes companies that are considered to be either non-compliant with state and federal laws in the countries in which they operate and/or directly involved in the production and/or distribution of cannabis and/or cannabis-derived products containing more than hemp-defined levels of tetrahydrocannabinol for the recreational consumer market. The index follows a modified liquidity-based weighting scheme where companies with higher liquidity achieve a bigger weight in the index|
The Rize Medical Cannabis and Life Sciences UCITS ETF (FLWR) seeks to invest in...
Read full aim for Rize ICAV
|Ongoing Charge (OCF/TER):||0.65%|
In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.
|SCOTTS MIRACLE-GRO CO||16.93%|
|ARENA PHARMACEUTICALS INC||7.82%|
|CORBUS PHARMACEUTICALS HLDGS INC||7.25%|
|ZYNERBA PHARMACEUTICALS INC||5.93%|
|TEVA PHARMACEUTICAL INDUSTRIES||2.50%|
|INDIA GLOBALIZATION CAPITAL INC||2.49%|
Recently viewed shares
Recently viewed investments
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.